Cabot Global Stocks Explorer Bi-weekly Update
The big news pertaining to global investing is the signing in Washington yesterday of the phase-one “truce” trade deal between America and China.
Read More
capital market
Read More
capital market Archives
What is the NASDAQ Composite Index?
The NASDAQ Composite Index is a Representation of the Equities Listed on the NASDAQ Exchange
The NASDAQ Composite Index began life in 1971 as an electronic price quotation system (the name comes from National Association of Securities Dealers Automated Quotations). The NASDAQ service gradually into...
Read More
Cabot Global Stocks Explorer Bi-weekly Update
For the most part, global stock markets performed strongly in 2019. But if you dig a bit deeper, you will see sizable and interesting gaps between countries.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
We are so accustomed to looking at stocks and markets day by day that we sometimes miss the big trends as well as opportunities.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
The Cabot Global Stocks Explorer portfolio is doing well in 2019 and a number of recommendations have recently surged on the strength of impressive earnings and an improving environment for emerging and international stocks.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Our emerging markets timer strengthened this week as the EEM climbed over 44 today, just short of its high for the year.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
The Financial Times this week reported that Beijing is preparing plans to remove Hong Kong’s chief executive, Carrie Lam, whose term is not up until 2022, as anti-government protests in the city intensified.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Today marks the first face-to-face talks between senior officials from America and China since July.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Our portfolio advanced this week led by India’s ICICI (IBN), which was up 19% on the back of a tax cut and prospects for higher growth.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
It was a pretty quiet week with most of our stocks up in the 3% -5% range. There are no changes to the portfolio.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Hopefully, we can all gain from the growing realization that while America and China will be fierce rivals for some time—they can also benefit from playing some ball with each other.
Read More
Cabot Global Stocks Explorer Bi-weekly Update
Emerging and international markets are holding their own as U.S. markets hit new highs in the wake of modest interest rate cuts by the Fed.
Read More
Cabot Emerging Markets Investor Bi-weekly Update
Our emerging markets (EEM) signal continues to be positive and right on top of its 20-day moving average as China and other emerging markets are bumping along and lacking a decisive uptrend.
Read More
Cabot Emerging Markets Investor Bi-weekly Update
The G-20 meetings in Japan yielded only incremental progress. This was grudgingly accepted as a positive by markets with most emerging market stocks getting a boost as we headed into a slow and short week.
Read More
Daily Alert – 6/7/19
This Brazilian bank is forecasted to grow at an annual rate of 48.48% over the next five years.
Read More
3 Streaming Stocks to Buy Now
Streaming companies have completely changed the way we watch TV and movies. And these three streaming stocks are best positioned to dominate the landscape.
Read More
Wall Street’s Best Dividend Digest Daily Alert
Wall Street is expecting double-digit growth from this real estate finance company. The shares have a current dividend yield of 7.51%, paid quarterly.
Read More
Boring Can Be Good!
I first learned about our Spotlight Stock, National Retail Properties (NNN) back in 2000, when I was writing my UnTapped Opportunities newsletter. At that time, I traveled to Orlando to meet with the company’s CFO, Kevin Habicht (who is still the company’s CFO—you to...
Read More
The Rhodes Report
Published since 2001, The Rhodes Report is a daily financial newsletter that provides short- to intermediate-term trading recommendations based on technical and qualitative valuation analysis. Distributed each morning in advance of the U.S. market open, The Rhodes Report provides a strategic forecast for and...
Read More
Cellular Biomedicine Group Inc. (CBMG)
This drug company develops treatments for cancerous and degenerative diseases in Greater China. The listing of the shares was just upgraded from the NASDAQ Capital Market to the NASDAQ Global Market, which should bring additional exposure for the company.
Cellular Biomedicine Group Inc. (CBMG)
from Medical...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up